Oxidative Stress in β-Thalassemia.

Area of Science:

• Biochemistry
• Hematology
• Pathology

Background:

• Cellular oxidative status, the balance between oxidants and antioxidants, is crucial for normal function.
• Pathological conditions can lead to oxidative stress, causing cell damage and organ failure.
• Thalassemia, a genetic hemolytic anemia, involves mutations in globin genes.

Purpose of the Study:

• To summarize the role of oxidative stress in β-thalassemia.
• To review current and potential antioxidative therapeutics for β-thalassemia.
• To explore methodologies for a theranostics approach to managing oxidative stress in thalassemia patients.

Main Methods:

• Literature review on oxidative stress in β-thalassemia.
• Analysis of factors influencing patient oxidative status.
• Discussion of cellular methodologies for theranostics.

Main Results:

• Oxidative stress, stemming from unstable hemoglobin degradation and iron overload, worsens thalassemia symptoms.
• Aggravated symptoms include increased hemolysis, ineffective erythropoiesis, and vital organ dysfunction.
• Patient oxidative status is influenced by genetic, environmental, and clinical factors.

Conclusions:

• Oxidative stress significantly mediates thalassemia pathologies.
• Personalized theranostics, utilizing diagnostic tests for targeted therapy, are vital for optimal treatment.
• Antioxidative strategies and theranostics hold promise for managing oxidative stress in β-thalassemia.